Company profile: SFJ Pharmaceuticals
1.1 - Company Overview
Company description
- Provider of strategic funding and joint-development partnerships, offering resources to accelerate clinical development and pharmaceutical asset approval, including trial design and execution; risk capital and expertise to support regulatory approvals across regions; and global clinical development resources for expedited approvals and lifecycle management.
Products and services
- Strategic Funding and Joint-Development: SFJ architects custom-engineered funding and co-development systems that accelerate clinical programs via strategic capital and partnerships, letting Pharma/Biotech be hands off or hands on as desired
- Pipeline/Asset Acceleration: SFJ offers regulatory-grade development components to enhance pharmaceutical asset value and approval prospects through trial design and execution, optimizing market reach and compressing timelines in major markets
- Risk Capital and Expertise: SFJ delivers multi-region risk capital and regulatory expertise, assuming clinical development risks and supporting approval processes across multiple regions to speed innovative drug availability
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to SFJ Pharmaceuticals
Impopharma
HQ: Canada
Website
- Description: Provider of comprehensive drug product formulation and process development, along with wide-ranging analytical testing services for the pharmaceutical industry, specializing in nasal and pulmonary drug products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Impopharma company profile →
Bioqual
HQ: United States
Website
- Description: Provider of AAALAC-accredited pre-clinical research and model development services, offering in vivo studies in small and large animal models, in vitro services (sample processing, virus stock generation, and assays including virus neutralization, hemagglutination inhibition, and quantitative PCR), vaccine evaluation (therapeutics and microbicides), drug therapy testing, and consulting.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bioqual company profile →
Prince Sterilization
HQ: United States
Website
- Description: Provider of medical device sterilization services, offering steam sterilization to eliminate all forms of microbial life, low-temp vaporized hydrogen peroxide sterilization for heat-sensitive equipment, and dry heat sterilization for materials that withstand high temperatures.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Prince Sterilization company profile →
Irisys
HQ: United States
Website
- Description: Provider of contract pharmaceutical product development and manufacturing services, offering pharmaceutical research and development and formulation development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Irisys company profile →
ZebraSci
HQ: United States
Website
- Description: Provider of inspections, testing, life cycle management, regulatory, and medical device development services for healthcare, specializing in combination product development and testing (pharma packaging and drug stability), drug device design verification, container closure integrity (CCI) testing, silicone characterization for parenteral containers using FlexHD, and drug delivery device selection and evaluation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ZebraSci company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for SFJ Pharmaceuticals
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to SFJ Pharmaceuticals
2.2 - Growth funds investing in similar companies to SFJ Pharmaceuticals
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for SFJ Pharmaceuticals
4.2 - Public trading comparable groups for SFJ Pharmaceuticals
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →